The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma

NCT07506447 — Completed, 68 participants, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT07506447
StatusCompleted
Study typeObservational
Enrollment68 (Actual)
SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology (Other)
ConditionsFDG PET, Mucosal Melanoma
InterventionsTelephone follow-up (Other)
Datesstart 2021-01-01, primary completion 2025-05-08, completion 2026-03-13, first posted 2026-04-01, last updated 2026-04-01
Locations1 site in China

Related Papers Related Patents Related Grants Related Experts
All trials for FDG PET All trials for Mucosal Melanoma All trials of Telephone follow-up

-Summary

This project will target patients with histopathologically diagnosed mucosal melanoma using \[¹⁸F\]FDG PET/CT imaging for retrospective prognostic evaluation.The primary objective is to explore the value of \[¹⁸F\]FDG PET/CT imaging in the prognostic assessment of mucosal melanoma, and to determine the correlations between quantitative \[¹⁸F\]FDG PET parameters and progression-free survival (PFS) as well as overall survival (OS), so as to provide reference evidence for individualized treatment decision-making.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Mucosal Melanoma CohortOther: Telephone follow-upRetrospective cohort of mucosal melanoma patients who underwent \[18F\]FDG PET/CT for prognostic evaluation.
  • Telephone follow-up (Other): Telephone follow-up

+Outcome measures

Primary outcomes

  • Overall survival [Up to 4 years]: Overall survival (OS) is defined as the time elapsed from the date of the ¹⁸F-FDG PET/CT examination to the date of death.
  • Progression-free survival [Up to 4 years]: Progression-free survival (PFS) is defined as the time from the date of \[18F\]FDG PET/CT imaging to the earliest date of disease progression, recurrence, or death.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

1. Patients with histopathologically confirmed mucosal melanoma.

Exclusion Criteria:

1. Having another primary malignancy (other than mucosal melanoma).
2. Being lost to follow-up.
3. Being under 18 years of age.
4. Being pregnant or breastfeeding.

+Locations (1)

FacilityCityCountryStatus
Wuhan Union HospitalWuhan, HubeiChina